ACADIA Pharmaceuticals Inc (ACAD)
16.82
-0.25
(-1.46%)
USD |
NASDAQ |
Apr 19, 16:00
16.82
0.00 (0.00%)
After-Hours: 20:00
ACADIA Pharmaceuticals Cash from Operations (TTM): 16.70M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 16.70M |
| September 30, 2023 | -92.54M |
| June 30, 2023 | -34.31M |
| March 31, 2023 | -55.64M |
| December 31, 2022 | -114.04M |
| September 30, 2022 | -113.30M |
| June 30, 2022 | -129.64M |
| March 31, 2022 | -141.84M |
| December 31, 2021 | -125.66M |
| September 30, 2021 | -130.03M |
| June 30, 2021 | -135.76M |
| March 31, 2021 | -147.31M |
| December 31, 2020 | -136.17M |
| September 30, 2020 | -138.38M |
| June 30, 2020 | -134.44M |
| March 31, 2020 | -135.96M |
| December 31, 2019 | -151.13M |
| September 30, 2019 | -160.50M |
| June 30, 2019 | -183.93M |
| March 31, 2019 | -186.41M |
| December 31, 2018 | -167.47M |
| September 30, 2018 | -158.29M |
| June 30, 2018 | -174.41M |
| March 31, 2018 | -192.43M |
| December 31, 2017 | -217.76M |
| Date | Value |
|---|---|
| September 30, 2017 | -249.05M |
| June 30, 2017 | -239.91M |
| March 31, 2017 | -237.76M |
| December 31, 2016 | -208.41M |
| September 30, 2016 | -181.94M |
| June 30, 2016 | -164.53M |
| March 31, 2016 | -137.66M |
| December 31, 2015 | -121.80M |
| September 30, 2015 | -104.87M |
| June 30, 2015 | -90.50M |
| March 31, 2015 | -77.60M |
| December 31, 2014 | -66.43M |
| September 30, 2014 | -58.90M |
| June 30, 2014 | -50.89M |
| March 31, 2014 | -39.37M |
| December 31, 2013 | -31.77M |
| September 30, 2013 | -27.80M |
| June 30, 2013 | -23.63M |
| March 31, 2013 | -22.99M |
| December 31, 2012 | -21.63M |
| September 30, 2012 | -20.67M |
| June 30, 2012 | -19.54M |
| March 31, 2012 | -20.02M |
| December 31, 2011 | -19.90M |
| September 30, 2011 | -9.955M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-183.93M
Minimum
Jun 2019
16.70M
Maximum
Dec 2023
-118.10M
Average
-134.44M
Median
Jun 2020
Cash from Operations (TTM) Benchmarks
| Tonix Pharmaceuticals Holding Corp | -102.00M |
| Amylyx Pharmaceuticals Inc | 11.92M |
| Regulus Therapeutics Inc | -26.77M |
| Minerva Neurosciences Inc | -14.78M |
| Viking Therapeutics Inc | -73.38M |